All News #Library
Biotech
Holoclara wriggles into ph. 1, sets sights on immune disease
18 Dec 2024 //
FIERCE BIOTECH
Holoclara Selects Eosinophilic Esophagitis for HC002 Therapy
18 Dec 2024 //
BUSINESSWIRE

Market Place
Sourcing Support